159 related articles for article (PubMed ID: 12459392)
1. In regard to Nag et al., IJROBP 2002;52:33-48.
Leborgne F; Zubizarreta E
Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1577; author reply 1577. PubMed ID: 12459392
[No Abstract] [Full Text] [Related]
2. In regard to correspondence between Pötter et al. and Nag et al. (Int J Radiat Oncol Biol Phys 2005;62:293-295).
Narayan K; vanDyk S; Bernshaw DL
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):644-5; author reply 645-7. PubMed ID: 16168857
[No Abstract] [Full Text] [Related]
3. Recommendations for image-based intracavitary brachytherapy of cervix cancer: the GYN GEC ESTRO Working Group point of view: in regard to Nag et al. (Int J Radiat Oncol Biol Phys 2004;60:1160-1172).
Pötter R; Dimopoulos J; Kirisits C; Lang S; Haie-Meder C; Briot E; Dumas I; Van Limbergen E; De Brabandere M; Nulens A; Erickson B; Rownd J; Petrow P
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):293-5; author reply 295-6. PubMed ID: 15850940
[No Abstract] [Full Text] [Related]
4. The American Brachytherapy Society recommendations for low-dose-rate brachytherapy for carcinoma of the cervix.
Nag S; Chao C; Erickson B; Fowler J; Gupta N; Martinez A; Thomadsen B;
Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):33-48. PubMed ID: 11777620
[TBL] [Abstract][Full Text] [Related]
5. Dose and volume specification for reporting gynaecological brachytherapy: time for a change.
Visser AG; Symonds RP
Radiother Oncol; 2001 Jan; 58(1):1-4. PubMed ID: 11165673
[No Abstract] [Full Text] [Related]
6. [Radiotherapy of cervix and endometrial carcinoma].
Barillot I; Haie-Méder C; Charra Brunaud C; Peignaux K; Kerr C; Thomas L
Cancer Radiother; 2016 Sep; 20 Suppl():S189-95. PubMed ID: 27523423
[TBL] [Abstract][Full Text] [Related]
7. Tumor heterogeneity of FIGO Stage III carcinoma of the uterine cervix: in regard to Kim et al. (Int J Radiation Oncology Biol Phys 2009;75:1323-1328).
Chen SW; Liang JA
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1605-6; author reply 1606-7. PubMed ID: 20637983
[No Abstract] [Full Text] [Related]
8. [Significance of radiotherapy for the treatment of cervical cancer].
Rotte K
Gynakol Rundsch; 1987; 27 Suppl 2():1-10. PubMed ID: 3428702
[No Abstract] [Full Text] [Related]
9. [Radiotherapy and brachytherapy in advanced cancers of the cervix].
Haie-Meder C; Lartigau E; Gerbaulet A
Bull Cancer Radiother; 1996; 83(4):360-3. PubMed ID: 9081338
[No Abstract] [Full Text] [Related]
10. Dose-volume histogram parameters and late side effects in magnetic resonance image-guided adaptive cervical cancer brachytherapy: in regard to Georg et al. (Int J Radiat Oncol Biol Phys 2011;79:356-362).
Shi M; Wei L
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):315; author reply 315-6. PubMed ID: 21816293
[No Abstract] [Full Text] [Related]
11. [The value of adjuvant radio- or chemotherapy after primary surgical therapy of cervix cancer. 1. Adjuvant radiotherapy of cervix cancer].
Roth SL; Nitz U; Mosny D
Gynakologe; 1994 Apr; 27(2):89-95. PubMed ID: 8039748
[No Abstract] [Full Text] [Related]
12. [Interstitial radiotherapy in combined treatment of cervix cancer].
Nechushkin MI; Mar'ina LA; Zinov'ev NE; Strakhov VIu; Sakharova OV
Vopr Onkol; 1998; 44(5):518-21. PubMed ID: 9884706
[No Abstract] [Full Text] [Related]
13. Magnetic resonance image-based dose volume parameters and clinical outcome with high dose rate brachytherapy in cervical cancers--a validation of GYN GEC-ESTRO brachytherapy recommendations.
Mahantshetty U; Swamidas J; Khanna N; Engineer R; Merchant NH; Shrivastava S
Clin Oncol (R Coll Radiol); 2011 Jun; 23(5):376-7. PubMed ID: 21377847
[No Abstract] [Full Text] [Related]
14. In regard to the American Brachytherapy Society recommendations for 103palladium brachytherapy. Beyer et al. IJROBP 2000;47:273-275.
King P; Anderson RS
Int J Radiat Oncol Biol Phys; 2001 Mar; 49(3):899. PubMed ID: 11265655
[No Abstract] [Full Text] [Related]
15. Regarding IJROBP 40:1111-1116, 1998, and IJROBP 40:1237-1242, 1998.
Vikram B
Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):1169-70. PubMed ID: 10192371
[No Abstract] [Full Text] [Related]
16. J. Jassem on A. Mayer, et al. Primary radiotherapy of stage IIA/B-IIIB cervical carcinoma. A comparison of continuous versus sequential regimens. Strahlenther Onkol 2004;180:209-15 (No. 4).
Serkies K
Strahlenther Onkol; 2005 Jan; 181(1):54. PubMed ID: 15660194
[No Abstract] [Full Text] [Related]
17. Regeneration in cervix cancer after 252Cf neutron brachytherapy.
Maruyama Y; Wierzbicki J; Feola J; Urano M
Int J Radiat Oncol Biol Phys; 1990 Jul; 19(1):61-7. PubMed ID: 2380096
[TBL] [Abstract][Full Text] [Related]
18. Combined external and intracavitary irradiation in treatment of advanced cervical carcinomas: predictive factors for local tumor control and early recurrences.
Sorbe B; Bohr L; Karlsson L; Bermark B
Int J Oncol; 2010 Feb; 36(2):371-8. PubMed ID: 20043071
[TBL] [Abstract][Full Text] [Related]
19. Parametrial boost using midline shielding results in an unpredictable dose to tumor and organs at risk in combined external beam radiotherapy and brachytherapy for locally advanced cervical cancer.
Fenkell L; Assenholt M; Nielsen SK; Haie-Meder C; Pötter R; Lindegaard J; Tanderup K
Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1572-9. PubMed ID: 20800373
[TBL] [Abstract][Full Text] [Related]
20. Optimizing the dose rate and technique in cervical carcinoma--balancing cases versus complications.
Petereit DG; Fowler JF; Kinsella TJ
Int J Radiat Oncol Biol Phys; 1994 Jul; 29(5):1195-7. PubMed ID: 8083092
[No Abstract] [Full Text] [Related]
[Next] [New Search]
